Quick Summary
Osha (Ligusticum porteri) is a plant native to North America with limited clinical research available. Current evidence is primarily ecological and phytochemical, with no identified high-quality human clinical trials or meta-analyses confirming specific therapeutic effects or established safety profiles.
What is it?
Osha is a perennial herb belonging to the family Apiaceae. It grows naturally in mountainous regions of the southwestern United States and northern Mexico. The plant is recognized by its distinctive root and aromatic properties and has been noted in ethnobotanical studies for its traditional applications.
Traditional Uses
Historically, Osha has been used by indigenous peoples in North America for various purposes, including as a herbal remedy. Traditional applications focus on its use in addressing respiratory and digestive conditions, although these uses are based on cultural knowledge rather than modern clinical evidence.
Active Compounds
Phytochemical studies have identified several compounds in Osha, including essential oils and other secondary metabolites. However, specific active constituents responsible for any medicinal effects have not been conclusively characterized in human studies.
Potential Benefits with Evidence Levels
Evidence Level: Insufficient clinical evidence
Currently, no randomized controlled trials, systematic reviews, or meta-analyses have been conducted to directly evaluate the clinical benefits of Ligusticum porteri in humans. Existing research is mainly ecological or phytochemical, without clinical validation.
Side Effects
No documented adverse effects or toxicity reports from human clinical trials are available at this time. The overall safety profile of Osha remains unclear due to lack of clinical data.
Drug Interactions
There is no evidence or reports of drug interactions involving Ligusticum porteri in the current research literature.
Who Should Avoid It
No specific contraindications have been established due to the absence of sufficient clinical research data. Caution is particularly advised for pregnant or breastfeeding individuals, as no safety data exist for these populations.
Evidence Limitations
- Almost all research pertains to plant ecology, phytochemistry, or agricultural propagation rather than clinical outcomes.
- No human randomized controlled trials, systematic reviews, or meta-analyses involving Osha were identified.
- Lack of data on pharmacology, toxicology, dosing, safety, and efficacy in humans limits clinical applicability.
References
- Humphrey PT, Gloss AD, Frazier J, Nelson-Dittrich AC, Faries S, Whiteman NK. Heritable plant phenotypes track light and herbivory levels at fine spatial scales. Oecologia. 2018; doi: 10.1007/s00442-018-4116-4. PMID: 29603095.
- American Herbal Pharmacopoeia. Ligusticum porteri J. M. Coult. & Rose. CRC Press; 2010. doi: 10.1201/b10413-82.
- Chemotypic variation in oshá (Ligusticum porteri) in Colorado, USA. Journal of Applied Research on Medicinal and Aromatic Plants. 2018; doi: 10.1016/j.jarmap.2018.05.001. Elsevier BV.
- Oshá (bear root) Ligusticum porteri J.M. Coult. & Rose var. porteri. Native Plants Journal. 2009; doi: 10.2979/npj.2009.10.2.110. University of Wisconsin Press.
- Meredith, C.R. & Applequist, W.L. Ligusticum porteri. IUCN Red List of Threatened Species. 2018; doi: 10.2305/iucn.uk.2020-3.rlts.t116995418a120916883.en. IUCN.
Last Reviewed
June 2024
Disclaimer: This information is provided for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any new herbal supplement, especially to discuss potential interactions or contraindications based on your individual health condition.